8-substituted xanthines as antagonists at A1- and A2-adenosine receptors

Kenneth A. Jacobson, Richard De La Cruz, Richard Schulick, Leonidas Kiriasis, William Padgett, Wolfgang Pfleiderer, Kenneth L. Kirk, John L. Neumeyer, John W. Daly

Research output: Contribution to journalArticle

Abstract

Two classes of 8-substituted analogs of theophylline (1,3-dialkylxanthines), having 8-cycloalkyl, 8-cycloalkenyl or 8-(para-substituted aryl) groups, were shown to be potent and, in some cases, receptor subtype selective antagonists at A1- and A2-adenosine receptors. New analogs based on a functionalized cogener approach and on classical medicinal chemical approaches were prepared. Affinity at A1-adenosine receptors was evaluated by inhibition of binding of [3H]N6-phenylisopropyladenosine to rat brain membranes. Activity at A2-adenosine receptors was measured by the reversal of 5'-N-ethylcarboxamidoadenosine (NECA)-stimulated production of cyclic AMP in membranes from rat pheochromocytoma PC12 cells. Cycloalkenyl analogs containing rigid olefinic bonds differed greatly in potency from the saturated analogs. The selectivity of phenylsulfonamide analogs depended on distal structural features. Novel xanthine analogs include diamino-, thiol-, aldehyde, and halogen-substituted derivatives, peptide conjugates of 8-[4-[2-aminoethylaminocarbonylmethyloxy]phenyl]1,3-dipropylxanthine (XAC), and a hydroxyethylamide analog of XAC.

Original languageEnglish (US)
Pages (from-to)3653-3661
Number of pages9
JournalBiochemical Pharmacology
Volume37
Issue number19
DOIs
StatePublished - Oct 1 1988
Externally publishedYes

Fingerprint

Xanthines
Adenosine A2 Receptors
Adenosine A1 Receptors
Rats
Phenylisopropyladenosine
Adenosine-5'-(N-ethylcarboxamide)
Membranes
Halogens
Xanthine
PC12 Cells
Pheochromocytoma
Theophylline
Sulfhydryl Compounds
Aldehydes
Cyclic AMP
Brain
Derivatives
Peptides

ASJC Scopus subject areas

  • Pharmacology

Cite this

Jacobson, K. A., De La Cruz, R., Schulick, R., Kiriasis, L., Padgett, W., Pfleiderer, W., ... Daly, J. W. (1988). 8-substituted xanthines as antagonists at A1- and A2-adenosine receptors. Biochemical Pharmacology, 37(19), 3653-3661. https://doi.org/10.1016/0006-2952(88)90398-X

8-substituted xanthines as antagonists at A1- and A2-adenosine receptors. / Jacobson, Kenneth A.; De La Cruz, Richard; Schulick, Richard; Kiriasis, Leonidas; Padgett, William; Pfleiderer, Wolfgang; Kirk, Kenneth L.; Neumeyer, John L.; Daly, John W.

In: Biochemical Pharmacology, Vol. 37, No. 19, 01.10.1988, p. 3653-3661.

Research output: Contribution to journalArticle

Jacobson, KA, De La Cruz, R, Schulick, R, Kiriasis, L, Padgett, W, Pfleiderer, W, Kirk, KL, Neumeyer, JL & Daly, JW 1988, '8-substituted xanthines as antagonists at A1- and A2-adenosine receptors', Biochemical Pharmacology, vol. 37, no. 19, pp. 3653-3661. https://doi.org/10.1016/0006-2952(88)90398-X
Jacobson KA, De La Cruz R, Schulick R, Kiriasis L, Padgett W, Pfleiderer W et al. 8-substituted xanthines as antagonists at A1- and A2-adenosine receptors. Biochemical Pharmacology. 1988 Oct 1;37(19):3653-3661. https://doi.org/10.1016/0006-2952(88)90398-X
Jacobson, Kenneth A. ; De La Cruz, Richard ; Schulick, Richard ; Kiriasis, Leonidas ; Padgett, William ; Pfleiderer, Wolfgang ; Kirk, Kenneth L. ; Neumeyer, John L. ; Daly, John W. / 8-substituted xanthines as antagonists at A1- and A2-adenosine receptors. In: Biochemical Pharmacology. 1988 ; Vol. 37, No. 19. pp. 3653-3661.
@article{c5005ac24fa74465942563a232edd1ea,
title = "8-substituted xanthines as antagonists at A1- and A2-adenosine receptors",
abstract = "Two classes of 8-substituted analogs of theophylline (1,3-dialkylxanthines), having 8-cycloalkyl, 8-cycloalkenyl or 8-(para-substituted aryl) groups, were shown to be potent and, in some cases, receptor subtype selective antagonists at A1- and A2-adenosine receptors. New analogs based on a functionalized cogener approach and on classical medicinal chemical approaches were prepared. Affinity at A1-adenosine receptors was evaluated by inhibition of binding of [3H]N6-phenylisopropyladenosine to rat brain membranes. Activity at A2-adenosine receptors was measured by the reversal of 5'-N-ethylcarboxamidoadenosine (NECA)-stimulated production of cyclic AMP in membranes from rat pheochromocytoma PC12 cells. Cycloalkenyl analogs containing rigid olefinic bonds differed greatly in potency from the saturated analogs. The selectivity of phenylsulfonamide analogs depended on distal structural features. Novel xanthine analogs include diamino-, thiol-, aldehyde, and halogen-substituted derivatives, peptide conjugates of 8-[4-[2-aminoethylaminocarbonylmethyloxy]phenyl]1,3-dipropylxanthine (XAC), and a hydroxyethylamide analog of XAC.",
author = "Jacobson, {Kenneth A.} and {De La Cruz}, Richard and Richard Schulick and Leonidas Kiriasis and William Padgett and Wolfgang Pfleiderer and Kirk, {Kenneth L.} and Neumeyer, {John L.} and Daly, {John W.}",
year = "1988",
month = "10",
day = "1",
doi = "10.1016/0006-2952(88)90398-X",
language = "English (US)",
volume = "37",
pages = "3653--3661",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "19",

}

TY - JOUR

T1 - 8-substituted xanthines as antagonists at A1- and A2-adenosine receptors

AU - Jacobson, Kenneth A.

AU - De La Cruz, Richard

AU - Schulick, Richard

AU - Kiriasis, Leonidas

AU - Padgett, William

AU - Pfleiderer, Wolfgang

AU - Kirk, Kenneth L.

AU - Neumeyer, John L.

AU - Daly, John W.

PY - 1988/10/1

Y1 - 1988/10/1

N2 - Two classes of 8-substituted analogs of theophylline (1,3-dialkylxanthines), having 8-cycloalkyl, 8-cycloalkenyl or 8-(para-substituted aryl) groups, were shown to be potent and, in some cases, receptor subtype selective antagonists at A1- and A2-adenosine receptors. New analogs based on a functionalized cogener approach and on classical medicinal chemical approaches were prepared. Affinity at A1-adenosine receptors was evaluated by inhibition of binding of [3H]N6-phenylisopropyladenosine to rat brain membranes. Activity at A2-adenosine receptors was measured by the reversal of 5'-N-ethylcarboxamidoadenosine (NECA)-stimulated production of cyclic AMP in membranes from rat pheochromocytoma PC12 cells. Cycloalkenyl analogs containing rigid olefinic bonds differed greatly in potency from the saturated analogs. The selectivity of phenylsulfonamide analogs depended on distal structural features. Novel xanthine analogs include diamino-, thiol-, aldehyde, and halogen-substituted derivatives, peptide conjugates of 8-[4-[2-aminoethylaminocarbonylmethyloxy]phenyl]1,3-dipropylxanthine (XAC), and a hydroxyethylamide analog of XAC.

AB - Two classes of 8-substituted analogs of theophylline (1,3-dialkylxanthines), having 8-cycloalkyl, 8-cycloalkenyl or 8-(para-substituted aryl) groups, were shown to be potent and, in some cases, receptor subtype selective antagonists at A1- and A2-adenosine receptors. New analogs based on a functionalized cogener approach and on classical medicinal chemical approaches were prepared. Affinity at A1-adenosine receptors was evaluated by inhibition of binding of [3H]N6-phenylisopropyladenosine to rat brain membranes. Activity at A2-adenosine receptors was measured by the reversal of 5'-N-ethylcarboxamidoadenosine (NECA)-stimulated production of cyclic AMP in membranes from rat pheochromocytoma PC12 cells. Cycloalkenyl analogs containing rigid olefinic bonds differed greatly in potency from the saturated analogs. The selectivity of phenylsulfonamide analogs depended on distal structural features. Novel xanthine analogs include diamino-, thiol-, aldehyde, and halogen-substituted derivatives, peptide conjugates of 8-[4-[2-aminoethylaminocarbonylmethyloxy]phenyl]1,3-dipropylxanthine (XAC), and a hydroxyethylamide analog of XAC.

UR - http://www.scopus.com/inward/record.url?scp=0023765214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023765214&partnerID=8YFLogxK

U2 - 10.1016/0006-2952(88)90398-X

DO - 10.1016/0006-2952(88)90398-X

M3 - Article

C2 - 3178879

AN - SCOPUS:0023765214

VL - 37

SP - 3653

EP - 3661

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 19

ER -